147 related articles for article (PubMed ID: 37772239)
1. Frequency of Gastroparesis Symptoms in Patients With Type-2 Diabetes Mellitus at a Tertiary Care Hospital in Pakistan.
Asif MS; Khan MKG; Nabeel MA; Ashfaq T; Nasir A; Abdullah RM; Kareem MAF
Cureus; 2023 Aug; 15(8):e44236. PubMed ID: 37772239
[TBL] [Abstract][Full Text] [Related]
2. Gastroparesis-Related Symptoms in Patients With Type 2 Diabetes Mellitus: Early Detection, Risk Factors, and Prevalence.
Asghar S; Asghar S; Shahid S; Sajjad H; Abdul Nasir J; Usman M
Cureus; 2023 Mar; 15(3):e35787. PubMed ID: 37025723
[TBL] [Abstract][Full Text] [Related]
3. Gender aspects suggestive of gastroparesis in patients with diabetes mellitus: a cross-sectional survey.
Dickman R; Wainstein J; Glezerman M; Niv Y; Boaz M
BMC Gastroenterol; 2014 Feb; 14():34. PubMed ID: 24552174
[TBL] [Abstract][Full Text] [Related]
4. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes.
Almogbel RA; Alhussan FA; Alnasser SA; Algeffari MA
Int J Health Sci (Qassim); 2016 Jul; 10(3):397-404. PubMed ID: 27610063
[TBL] [Abstract][Full Text] [Related]
6. Obesity and symptoms suggestive of gastroparesis in patients with type 2 diabetes and neuropathy.
Boaz M; Kislov J; Dickman R; Wainstein J
J Diabetes Complications; 2011; 25(5):325-8. PubMed ID: 21813291
[TBL] [Abstract][Full Text] [Related]
7. Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.
Li JL; Li M; Pang B; Zhou Q; Tian JX; Liu HX; Zhao XY; Tong XL
World J Gastroenterol; 2014 Jul; 20(26):8674-80. PubMed ID: 25024625
[TBL] [Abstract][Full Text] [Related]
8. Symptoms Suggestive of Gastroparesis in a Community-Based Cohort of European Americans and African Americans with Type 2 Diabetes Mellitus.
Brown LK; Xu J; Freedman BI; Hsu FC; Bowden DW; Koch KL
Dig Dis Sci; 2020 Aug; 65(8):2321-2330. PubMed ID: 31820181
[TBL] [Abstract][Full Text] [Related]
9. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
Heckert J; Parkman HP
Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
[TBL] [Abstract][Full Text] [Related]
11. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
Qual Life Res; 2004 May; 13(4):833-44. PubMed ID: 15129893
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus.
Dickman R; Kislov J; Boaz M; Ron Y; Beniashvili Z; Raz I; Baigel I; Niv Y; Wainstein J
J Diabetes Complications; 2013; 27(4):376-9. PubMed ID: 23507560
[TBL] [Abstract][Full Text] [Related]
13. Effect of
Mahjoub F; Salari R; Yousefi M; Mohebbi M; Saki A; Rezayat KA
Electron Physician; 2018 Jul; 10(7):6997-7007. PubMed ID: 30128090
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.
Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
Aliment Pharmacol Ther; 2003 Jul; 18(1):141-50. PubMed ID: 12848636
[TBL] [Abstract][Full Text] [Related]
15. The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis.
Revicki DA; Lavoie S; Speck RM; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
J Patient Rep Outcomes; 2018 Dec; 2(1):61. PubMed ID: 30547386
[TBL] [Abstract][Full Text] [Related]
16. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
[TBL] [Abstract][Full Text] [Related]
17. Bloating in gastroparesis: severity, impact, and associated factors.
Hasler WL; Wilson LA; Parkman HP; Nguyen L; Abell TL; Koch KL; Pasricha PJ; Snape WJ; Farrugia G; Lee L; Tonascia J; Unalp-Arida A; Hamilton F;
Am J Gastroenterol; 2011 Aug; 106(8):1492-502. PubMed ID: 21483459
[TBL] [Abstract][Full Text] [Related]
18. Both gastric electrical stimulation and pyloric surgery offer long-term symptom improvement in patients with gastroparesis.
Marowski S; Xu Y; Greenberg JA; Funk LM; Lidor AO; Shada AL
Surg Endosc; 2021 Aug; 35(8):4794-4804. PubMed ID: 33025250
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
20. Symptom variability throughout the day in patients with gastroparesis.
Shahsavari D; Yu D; Jehangir A; Lu X; Zoll B; Parkman HP
Neurogastroenterol Motil; 2020 Feb; 32(2):e13740. PubMed ID: 31782211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
